Library

Autor(en) Titel Quelle Links
Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan J, Cohen BH, D'Angio G, Kramer ED, Zimmerman RA, et al. Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 1991, 74: 433    
Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS, Mulne L, Boyett J, D'Angio G, Wechsler-Jentzsch K, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994, 81: 690    
Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, Muraszko K, Rorke LB, Wara WM, Cohen BH, Boyett JM Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol 1999, 17: 2127    
Packer RJ, Gurney JG, Punyko JA, Donaldson SS, Inskip PD, Stovall M, Yasui Y, Mertens AC, Sklar CA, Nicholson HS, Zeltzer LK, Neglia JP, Robison LL Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003 Sep 1; 21: 3255    
Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2006, 24: 4202    
Pachlopnik Schmid, J Hämophagozytose-Syndrome. PAEDIATRICA 2011, Vol. 22 Nr. 4, S.13    
Packer RJ, Zhou T, Holmes E, Vezina G, Gajjar A Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961. Neuro-oncology 2013, 15: 97    
Packer RJ, Pfister S, Bouffet E, Avery R, Bandopadhayay P, Bornhorst M, Bowers DC, Ellison D, Fangusaro J, Foreman N, Fouladi M, Gajjar A, Haas-Kogan D, Hawkins C, Ho CY, Hwang E, Jabado N, Kilburn LB, Lassaletta A, Ligon KL, Massimino M, Meeteren SV, Mueller S, Nicolaides T, Perilongo G, Tabori U, Vezina G, Warren K, Witt O, Zhu Y, Jones DT, Kieran M Pediatric low-grade gliomas: implications of the biologic era. Neuro-oncology 2017, 19: 750    
Pagel J, Beutel K, Lehmberg K, Koch F, Maul-Pavicic A, Rohlfs AK, Al-Jefri A, Beier R, Bomme Ousager L, Ehlert K, Gross-Wieltsch U, Jorch N, Kremens B, Pekrun A, Sparber-Sauer M, Mejstrikova E, Wawer A, Ehl S, zur Stadt U, Janka G Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood 2012, 119: 6016    
Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, Wani K, Tatevossian R, Punchihewa C, Johann P, Reimand J, Warnatz HJ, Ryzhova M, Mack S, Ramaswamy V, Capper D, Schweizer L, Sieber L, Wittmann A, Huang Z, van Sluis P, Volckmann R, Koster J, Versteeg R, Fults D, Toledano H, Avigad S, Hoffman LM, Donson AM, Foreman N, Hewer E, Zitterbart K, Gilbert M, Armstrong TS, Gupta N, Allen JC, Karajannis MA, Zagzag D, Hasselblatt M, Kulozik AE, Witt O, Collins VP, von Hoff K, Rutkowski S, Pietsch T, Bader G, Yaspo ML, von Deimling A, Lichter P, Taylor MD, Gilbertson R, Ellison DW, Aldape K, Korshunov A, Kool M, Pfister SM Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. Cancer cell 2015, 27: 728    
Pajtler KW, Tippelt S, Siegler N, Reichling S, Zimmermann M, Mikasch R, Bode U, Gnekow A, Pietsch T, Benesch M, Rutkowski S, Fleischhack G Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors. Journal of neuro-oncology 2016, 128: 463    
Palagyi A, Neveling K, Plinninger U, Ziesch A, Targosz BS, Denk GU, Ochs S, Rizzani A, Meier D, Thasler WE, Hanenberg H, De Toni EN, Bassermann F, Schäfer C, Göke B, Schindler D, Gallmeier E Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents. Molecular cancer 2010, 9: 127    
Pane F, Intrieri M, Quintarelli C, Izzo B, Muccioli GC, Salvatore F BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations. Oncogene 2002, 21: 8652    
Pape H, Laws H, Burdach S, van Kaick B, Glag M, Gripp S, Wittkamp M, Jürgens H, Göbel U, Schmitt G Radiotherapy and high-dose chemotherapy in advanced Ewing's tumors. Strahlenther Onkol 1999, 175: 484    
Pappo AS, Dirksen U Rhabdomyosarcoma, Ewing Sarcoma, and Other Round Cell Sarcomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Jan 10; 36: 168    
Parlowsky T, Bucsky P, Hof M, Kaatsch P Malignant endocrine tumours in childhood and adolescence--results of a retrospective analysis. Klin Pädiatr 1996, 208: 205    
Parlowsky T, Bucsky P Aktueller Stand der interdisziplinären multizentrischen Therapiestudie "Maligne endokrine Tumoren im Kindes- und Jugendalter - GPOH-MET 97". Monatsschr. Kinderheilkd 2000, 148: 971 Abstr.    
Parlowsky T, Dralle H, Farahati J, Feyerabend T, Reiners C, Schmoll HJ, Bucsky P Maligne endokrine Tumoren im Kinds- und Jugendalter GPOH-MET 97. Deutsches Ärzteblatt 2001, 98:A 764-A 767    
Parulekar MV Retinoblastoma - current treatment and future direction. Early human development 2010, 86: 619    
Parsons K, Bernhardt B, Strickland B Targeted immunotherapy for high-risk neuroblastoma--the role of monoclonal antibodies. The Annals of pharmacotherapy 2013, 47: 210    
Partanen M, Kang G, Wang WC, Krull K, King AA, Schreiber JE, Porter JS, Hodges J, Hankins JS, Jacola LM Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease. Br J Haematol 2020 Feb 26; ePup    
Pastor V, Hirabayashi S, Karow A, Wehrle J, Kozyra EJ, Nienhold R, Ruzaike G, Lebrecht D, Yoshimi A, Niewisch M, Ripperger T, Göhring G, Baumann I, Schwarz S, Strahm B, Flotho C, Skoda RC, Niemeyer CM, Wlodarski MW Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants. Leukemia 2016, epub ahead of print    
Pastor V, Hirabayashi S, Karow A, Wehrle J, Kozyra EJ, Nienhold R, Ruzaike G, Lebrecht D, Yoshimi A, Niewisch M, Ripperger T, Göhring G, Baumann I, Schwarz S, Strahm B, Flotho C, Skoda RC, Niemeyer CM, Wlodarski MW Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants. Leukemia 2016, epub ahead of print    
Paulussen M, Bielack S, Jürgens H, Jost L, ESMO Guidelines Working Group Ewing's sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology 2008, 19 Suppl 2:ii97    
Paulussen M, Ahrens S, Burdach S, Craft A, Dunst J, Fröhlich B, Winkelmann W, Zoubek A, Jürgens H Primary metastatic (stage IV) Ewingtumor. Ann Oncol 1998, 9: 275    
Paulussen M, Ahrens S, Craft A, Dunst J, Fröhlich B, Jabar S, Winkelmann W, Wissing S, Zoubek A, Jürgens H Ewing tumors with primary lung metastases. J Clin Oncol 1998, 16: 3044    
Paulussen M, Ahrens S, Braun-Munzinger G, Craft A, Dörffel W, Dunst J, Fröhlich B, Göbel U, Haussler M, Klingebiel T, Koscielniak E, Mittler U, Rübe C, Winkelmann W, Voute P, Zoubek A, Jürgens H EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-- preliminary results. Klin Pädiatr 1999, 211: 276    
Paulino AC Trilateral retinoblastoma: is the location of the intracranial tumor important? Cancer 1999, 86: 135    
Paulussen M, Ahrens S, Dunst J, Winkelmann W, Exner G, Kotz R, Amann G, Dockhorn-Dworniczak B, Harms D, Muller-Weihrich S, Welte K, Kornhuber B, Janka-Schaub G, Göbel U, Treuner J, Voute P, Zoubek A, Gadner H, Jürgens H Localized Ewing tumor of bone. J Clin Oncol 2001, 19: 1818    
Paulussen M, Ahrens S, Lehnert M, Taeger D, Hense H, Wagner A, Dunst J, Harms D, Reiter A, Henze G, Niemeyer C, Göbel U, Kremens B, Folsch U, Aulitzky W, Voute P, Zoubek A, Jürgens H Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. Ann Oncol 2001, 12: 1619    
Paulussen M, Frohlich B, Jürgens H Ewing tumour: Incidence, prognosis and treatment options. Paediatr Drugs 2001, 3: 899    
Paulussen M, Poremba C, Schuck A, Winkelmann W, Dunst J, Jürgens H Behandlungskonzept des Ewing-Tumors. Onkologe 2001, 7: 428    
Paulussen M, Jürgens H Ewing-Sarkom und PNET. Buchbeitrag 2004    
Paulides M, Stöhr W, Bielack S, Jürgens H, Treuner J, Schuck A, Willich N, Sauer R, Dörr, HG, Rascher W, Langer T, Beck, JD Major sequelae of antineoplastic therapy prospectively evaluated in 162 relapse-free adult sarcoma patients. Onkologie 2005, 28;S3; 56    
Paulussen M, Kovar H, Jürgens H Ewing sarcoma and peripheral PNET. Buchbeitrag 2005, 5. Aufl.    
Paulussen M, Jürgens H, Dunst J, Schmoll, HJ, Winkelmann W, Hoffmann, C Ewing-Tumor (Ewing-Sarkom und maligner peripherer neuroektodermaler Tumor, PNET). Book Chapter In "Kompendium Internistische Onkologie, Standards in Diagnostik und Therapie - Teil 2: Therapiekonzepte maligner Tumoren" (Ed. Schmoll,H.J.; Höffken,K.; Possinger,K.) 2005, 4th Ed.; 5292    
Paulides M, Kremers A, Stohr W, Bielack S, Jürgens H, Treuner J, Beck JD, Langer T, German Late Effects Working Group in the Society of Pediatric Oncology and Haematology (GPOH) Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS). Pediatric blood & cancer 2006, 46: 489    
Paulides M, Stohr W, Bielack S, Jürgens H, Koscielniak E, Klingebiel T, Zimmermann R, Stachel D, Langer T, Beck JD Prospective evaluation of hepatitis B, C and HIV infections as possible sequelae of antineoplastic treatment in paediatric sarcoma patients: a report from the Late Effects Surveillance System. Oncology reports 2006, 15: 687    
Paulides M, Dörr HG, Stöhr W, Bielack S, Koscielniak E, Klingebiel T, Jürgens H, Bölling T, Willich N, Sauer R, Langer T, Beck JD, Late Effects Surveillance System Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System. Clinical endocrinology 2007, 66: 727    
Paulides M, Haupt R, Jankovic M, Möricke A, Langer T, Beck JD, ELTEC GroupELTEC members: E Frey, H Lackner, A Moser, Austria, R Maurus, J Otten, P Philippet, Belgium, JD Beck, G Calaminus, HG Dörr, T Langer, A Möricke, M Paulides, T Rau, Germany, MM Hawkins, A Taylor, Great Britain, E Magyarosy, Hungary, E Castagnola, A Colombini, F Fioredda, R Haupt (Chairman), M Jankovic, C Manganini (Secretary), C Micalizzi, P Reciputo, MG Valsecchi, Italy, JPM Bökkerink, W Tissing, The Netherlands, A Feldges, J Greiner, Swit Over 15 years of ELTEC: A report of the international BFM study group. Pediatric blood & cancer 2007, 49: 113-4; discussion 112    
Paulussen M, Craft AW, Lewis I, Hackshaw A, Douglas C, Dunst J, Schuck A, Winkelmann W, Köhler G, Poremba C, Zoubek A, Ladenstein R, van den Berg H, Hunold A, Cassoni A, Spooner D, Grimer R, Whelan J, McTiernan A, Jürgens H, European Intergroup Cooperative Ewing's Sarcoma Study-92 Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. Journal of clinical oncology 2008, 26: 4385    
Paulussen M, Bielack S, Jürgens H, Casali PG, ESMO Guidelines Working Group Ewing's sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology 2009, 20 Suppl 4: 140    
Paulides M, Stöhr W, Laws HJ, Graf N, Lakomek M, Berthold F, Schmitt K, Niggli F, Jürgens H, Bielack S, Koscielniak E, Klingebiel T, Langer T Immunity against tetanus and diphtheria after childhood sarcoma treatment. Klinische Padiatrie 2010, 222: 196    
Paulides M, Stöhr W, Laws HJ, Graf N, Lakomek M, Berthold F, Schmitt K, Niggli F, Jürgens H, Bielack S, Koscielniak E, Klingebiel T, Langer T Antibody levels against tetanus and diphtheria after polychemotherapy for childhood sarcoma: a report from the Late Effects Surveillance System. Vaccine 2011, 11; 29: 1565    
Paustian L, Chao MM, Hanenberg H, Schindler D, Neitzel H, Kratz CP, Ebell W Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany. Pediatric hematology and oncology 2016, 33: 5    
Paul U, Richter J, Stuhlmann-Laiesz C, Kreuz M, Nagel I, Horn H, Staiger AM, Aukema SM, Hummel M, Ott G, Spang R, Rosenwald A, Feller AC, Cogliatti S, Stein H, Hansmann ML, Moller P, Szczepanowski M, Burkhardt B, Pfreundschuh M, Schmitz N, Loeffler M, Truemper L, Siebert R, Klapper W Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC. Leukemia & lymphoma 2018, 59: 1213    
Pedersen-Bjeregaard J, Christiansen DH, Andersen MK, Skovby F Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities. Leukemia 2002, 16: 2177    
Peeters J, Meitert J, Paulides M, Beck JD, Langer T Late effects surveillance system after childhood cancer in Germany, austria and parts of Switzerland--update 2009. Strahlentherapie und Onkologie 2009, 185 Suppl 2: 5    
Peeters J, Meitert J, Paulides M, Wiener A, Beck JD, Calaminus G, Langer T Health-related quality of life (HRQL) in all-patients treated with chemotherapy only: a report from the late effects surveillance system in Germany. Klinische Padiatrie 2009, 221: 156    
Peffault de Latour R, Peters C, Gibson B, Strahm B, Lankester A, de Heredia CD, Longoni D, Fioredda F, Locatelli F, Yaniv I, Wachowiak J, Donadieu J, Lawitschka A, Bierings M, Wlodarski M, Corbacioglu S, Bonanomi S, Samarasinghe S, Leblanc T, Dufour C, Dalle JH, Pediatric Working Party of the European Group for Blood and Marrow Transplantation,Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes. Bone marrow transplantation 2015, 50: 1168    
Peifer M, Hertwig F, Roels F, Dreidax D, Gartlgruber M, Menon R, Krämer A, Roncaioli JL, Sand F, Heuckmann JM, Ikram F, Schmidt R, Ackermann S, Engesser A, Kahlert Y, Vogel W, Altmüller J, Nürnberg P, Thierry-Mieg J, Thierry-Mieg D, Mariappan A, Heynck S, Mariotti E, Henrich KO, Gloeckner C, Bosco G, Leuschner I, Schweiger MR, Savelyeva L, Watkins SC, Shao C, Bell E, Höfer T, Achter V, Lang U, Theissen J, Volland R, Saadati M, Eggert A, de Wilde B, Berthold F, Peng Z, Zhao C, Shi L, Ortmann M, Büttner R, Perner S, Hero B, Schramm A, Schulte JH, Herrmann C, O'Sullivan RJ, Westermann F, Thomas RK, Fischer M Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Nature 2015 Oct 29; 526: 700    
Peinemann F, van Dalen EC, Enk H, Berthold F Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation. The Cochrane database of systematic reviews 2017 Aug 25; 8:CD010685    
Peikert ML, Inhestern L, Krauth KA, Escherich G, Rutkowski S, Kandels D, Bergelt C Returning to daily life: a qualitative interview study on parents of childhood cancer survivors in Germany. BMJ open 2020 Mar 8; 10:e033730    
Perilongo G, Moras P, Carollo C, Battistella A, Clementi M, Laverda A, Murgia A Spontaneous partial regression of low-grade glioma in children with neurofibromatosis-1: a real possibility. J Child Neurol 1999, 14: 352. Review    
Perilongo G, Walker D, Taylor R, Zanetti I, Gnekow A, Garree M, Kühl J, Robinson K Vincristine (VCR) Carboplatin (BCDCA) in Hypothalamic-chiasmatic low grade glioma (HC-LGG). SIOP-LGG study report. Medical & Pediatric Oncology 2000, 35: 1    
Perrotta S, Gallagher PG, Mohandas N Hereditary spherocytosis. Lancet 2008 Oct 18; 372: 1411    
Perrotta S, Gallagher PG, Mohandas N Hereditary spherocytosis. Lancet 2008, 372: 1411    
Perrin GQ, Herzog RW, Markusic DM Update on clinical gene therapy for hemophilia. Blood 2019 Jan 31; 133: 407    
Peters O, Gnekow A, Rating D, Wolff J Childhood Low-Grade Oligodendroglioma. in press 2003    
Peters U, Preisler-Adams S, Lanvers-Kaminsky C, Jürgens H, Lamprecht-Dinnesen A Sequence variations of mitochondrial DNA and individual sensitivity to the ototoxic effect of cisplatin. Anticancer Res 2003, 23: 1249    
Peters O, Gnekow AK, Rating D, Wolff JE Impact of location on outcome in children with low-grade oligodendroglioma. Pediatric blood & cancer 2004, 43: 250    
Peters C, Schrauder A, Schrappe M, von Stackelberg A, Stary J, Yaniv I, Gadner H, Klingebiel T, BFM Study Group, the IBFM-Study Group and the Paediatric Disease Working Party of the EBMT Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM/IBFM/EBMT concepts. Bone marrow transplantation 2005, 35 Suppl 1:S9    
Petersen I, Spix C, Kaatsch P, Graf N, Janka G, Kollek R Parental informed consent in pediatric cancer trials: a population-based survey in Germany. Pediatric blood & cancer 2013, 60: 446    
Peters C, Schrappe M, von Stackelberg A, Schrauder A, Bader P, Ebell W, Lang P, Sykora KW, Schrum J, Kremens B, Ehlert K, Albert MH, Meisel R, Matthes-Martin S, Gungor T, Holter W, Strahm B, Gruhn B, Schulz A, Woessmann W, Poetschger U, Zimmermann M, Klingebiel T Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial. Journal of clinical oncology 2015, 33: 1265    
Peters C CAR-T-Zellen: Eine komplett neue Therapieoption bei Kindern und Jugendlichen. Spectrum Onkologie SO 06/2019    
Peters C, Dalle JH, Locatelli F, Poetschger U, Sedlacek P, Buechner J, Shaw PJ, Staciuk R, Ifversen M, Pichler H, Vettenranta K, Svec P, Aleinikova O, Stein J, Güngör T, Toporski J, Truong TH, Diaz-de-Heredia C, Bierings M, Ariffin H, Essa M, Burkhardt B, Schultz K, Meisel R, Lankester A, Ansari M, Schrappe M, IBFM Study Group,, von Stackelberg A, IntReALL Study Group, Balduzzi A, I-BFM SCT Study Group, Corbacioglu S, EBMT Paediatric Diseases Working Party, Bader P Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021, 39: 295    
Pfaff E, El Damaty A, Balasubramanian GP, Blattner-Johnson M, Worst BC, Stark S, Witt H, Pajtler KW, van Tilburg CM, Witt R, Milde T, Jakobs M, Fiesel P, Frühwald MC, Hernáiz Driever P, Thomale UW, Schuhmann MU, Metzler M, Bochennek K, Simon T, Dürken M, Karremann M, Knirsch S, Ebinger M, von Bueren AO, Pietsch T, Herold-Mende C, Reuss DE, Kiening K, Lichter P, Eggert A, Kramm CM, Pfister SM, Jones DTW, Bächli H, Witt O Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience. European journal of cancer 2019, 114: 27    
Pfister S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N, Toedt G, Wittmann A, Kratz C, Olbrich H, Ahmadi R, Thieme B, Joos S, Radlwimmer B, Kulozik A, Pietsch T, Herold-Mende C, Gnekow A, Reifenberger G, Korshunov A, Scheurlen W, Omran H, Lichter P BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. The Journal of clinical investigation 2008, 118: 1739    
Pfister S, Remke M, Benner A, Mendrzyk F, Toedt G, Felsberg J, Wittmann A, Devens F, Gerber NU, Joos S, Kulozik A, Reifenberger G, Rutkowski S, Wiestler OD, Radlwimmer B, Scheurlen W, Lichter P, Korshunov A Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. Journal of clinical oncology 2009, 27: 1627    
Pfitzer C, Zynda A, Hohmann C, Keil T, Borgmann-Staudt A Educational level of childhood brain tumor survivors: results from a German survey. Klinische Padiatrie 2013, 225: 138    
Pfitzer C, Chen CM, Wessel T, Keil T, Sörgel A, Langer T, Steinmann D, Borgmann-Staudt A Dynamics of fertility impairment in childhood brain tumour survivors. Journal of cancer research and clinical oncology 2014t; 140: 1759    
Pfitzer C, Orawa H, Balcerek M, Langer T, Dirksen U, Keslova P, Zubarovskaya N, Schuster FR, Jarisch A, Strauss G, Borgmann-Staudt A Dynamics of fertility impairment and recovery after allogeneic haematopoietic stem cell transplantation in childhood and adolescence: results from a longitudinal study. Journal of cancer research and clinical oncology 2015, 141: 135    
Philip T, Bergeron L Le lymphome de Burkitt: un modèle pour la cancérologie pédiatrique. Arch Pediatr 2000, 7: 924    
Pichler H, Möricke A, Mann G, Teigler-Schlegel A, Niggli F, Nebral K, König M, Inthal A, Krehan D, Dworzak MN, Janousek D, Harbott J, Schrappe M, Gadner H, Strehl S, Haas OA, Panzer-Grümayer R, Attarbaschi A, Berlin-Frankfurt-Münster (BFM) Study Group Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy. British journal of haematology 2010, 149: 93    
Pieters R, Den Boer M, Durian M, Janka G, Schmiegelow K, Kaspers G, van Wering E, Veerman A Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants. Leukemia 1998, 12: 1344    
Pieters R, Schrappe M, De Lorenzo P, Hann I, De Rossi G, Felice M, Hovi L, LeBlanc T, Szczepanski T, Ferster A, Janka G, Rubnitz J, Silverman L, Stary J, Campbell M, Li CK, Mann G, Suppiah R, Biondi A, Vora A, Valsecchi MG A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007, 370: 240    
Pieper S, Ranft A, Braun-Munzinger G, Jürgens H, Paulussen M, Dirksen U Ewing's tumors over the age of 40: a retrospective analysis of 47 patients treated according to the International Clinical Trials EICESS 92 and EURO-E. W.I. N.G. 99. Onkologie 2008, 31: 657    
Pietsch T, Schmidt R, Remke M, Korshunov A, Hovestadt V, Jones DT, Felsberg J, Kaulich K, Goschzik T, Kool M, Northcott PA, von Hoff K, von Bueren AO, Friedrich C, Mynarek M, Skladny H, Fleischhack G, Taylor MD, Cremer F, Lichter P, Faldum A, Reifenberger G, Rutkowski S, Pfister SM Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort. Acta neuropathologica 2014, 128: 137    
Piel FB, Steinberg MH, Rees DC Sickle Cell Disease. The New England journal of medicine 2017, 376: 1561    
Pieters R, De Lorenzo P, Ancliffe P, Aversa LA, Brethon B, Biondi A, Campbell M, Escherich G, Ferster A, Gardner RA, Kotecha RS, Lausen B, Li CK, Locatelli F, Attarbaschi A, Peters C, Rubnitz JE, Silverman LB, Stary J, Szczepanski T, Vora A, Schrappe M, Valsecchi MG Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study. Journal of clinical oncology 2019, 37: 2246    
Piga A, Perrotta S, Gamberini MR, Voskaridou E, Melpignano A, Filosa A, Caruso V, Pietrangelo A, Longo F, Tartaglione I, Borgna-Pignatti C, Zhang X, Laadem A, Sherman ML, Attie KM Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with ß-thalassemia. Blood 2019, 133: 1279    
Pilz T, Pilgrim T, Bisogno G, Knietig R, Koscielniak E, Carli M, Treuner J Chemotherapy in fibromatoses of childhood and adolescence. Klinische Pädiatrie 1999, 211: 291    
Pinkwart C, Stiefel M, Mauz-Körholz C, Körholz D [Akute Psychose bei einer jugendlichen Patientin während der Therapie eines nodulären lymphozytenprädominanten Hodgkin-Lymphoms (nLPHL) Stadium IIB]. Klinische Padiatrie 2011, 223: 370    
Pirenne F Prevention of delayed hemolytic transfusion reaction. Transfus clin biol 2019, 26: 99    
Pitsika M, Tsitouras V Cerebellar mutism. Journal of neurosurgery. Pediatrics 2013, 12: 604    
Pizzo PA, Poplack DG (eds) Principles and Practise of Pediatric Oncology. Lippincott Williams & Wilkins Fifth edition 2006    
Platzbecker U, Avvisati G, Cicconi L, Thiede C, Paoloni F, Vignetti M, Ferrara F, Divona M, Albano F, Efficace F, Fazi P, Sborgia M, Di Bona E, Breccia M, Borlenghi E, Cairoli R, Rambaldi A, Melillo L, La Nasa G, Fiedler W, Brossart P, Hertenstein B, Salih HR, Wattad M, Lübbert M, Brandts CH, Hänel M, Röllig C, Schmitz N, Link H, Frairia C, Pogliani EM, Fozza C, D'Arco AM, Di Renzo N, Cortelezzi A, Fabbiano F, Döhner K, Ganser A, Döhner H, Amadori S, Mandelli F, Ehninger G, Schlenk RF, Lo-Coco F Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Feb 20; 35: 605    
Poetschke-Langer, M Krebsprävention und Gesundheitsförderung: Was Hänschen nicht lernt .. - Themen der Zeit: Berichte. Deutsches Ärzteblatt 1998, 95: A-1364 / B-1160 / C    
Pötzsch B, Madlener K (Hrsg) Hämostaseologie. Springer Verlag 2010    
Pollack IF Brain tumors in children. N Engl J Med 1994, 331: 1500    
Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg 1995, 82: 536    
Pommerening K, Miller M, Schmidtmann I, Michaelis J Pseudonyms for cancer registries. Methods Inf Med 1996, 35: 112    
Pommerening K, Debling D, Kaatsch P, Blettner M [Registries for rare diseases. Compliance and data protection]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2008, 51: 491    
Poon MC, Di Minno G, d'Oiron R, Zotz R New Insights Into the Treatment of Glanzmann Thrombasthenia. Transfusion medicine reviews 2016, 30: 92    
Poremba C, Willenbring H, Hero B, Christiansen H, Schafer K, Brinkschmidt C, Jürgens H, Bocker W, Dockhorn-Dworniczak B Telomerase activity distinguishes between neuroblastomas with good and poor prognosis. Ann Oncol 1999, 10: 715    
Poremba C, Hero B, Heine B, Scheel C, Schaefer K, Christiansen H, Berthold F, Kneif S, Stein H, Jürgens H, Boecker W, Dockhorn-Dworniczak B Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas. Med Pediatr Oncol 2000, 35: 651    
Poremba C, Scheel C, Hero B, Christiansen H, Schaefer K, Nakayama J, Berthold F, Jürgens H, Boecker W, Dockhorn-Dworniczak B Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma. J Clin Oncol 2000, 18: 2582    
Poremba C, Hero B, Goertz H, Scheel C, Wai D, Schaefer K, Christiansen H, Berthold F, Jürgens H, Boecker W, Dockhorn-Dworniczak B Traditional and emerging molecular markers in neuroblastoma prognosis. Klin Pädiatr 2001, 213: 186    
Porcu P, Farag S, Marcucci G, Cataland SR, Kennedy MS, Bissell M Leukocytoreduction for acute leukemia. Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 2002, 6: 15    
Porcu P, Farag S, Marcucci G, Cataland SR, Kennedy MS, Bissell M Leukocytoreduction for acute leukemia. Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 2002, 6: 15    
Posl M, Amling M, Werner M, Basler I, Salzer-Kuntschik M, Winkler K, Delling G Osteosarcoma-apoptosis and proliferation. Study of bcl-2 expression. Pathologe 1994, 15: 337    
Posl M, Grahl K, Amling M, Werner M, Ritzel H, Stenzel I, Hentz M, Winkler K, Delling G P-glycoprotein expression in osteosarcoma. Pathologe 1996, 17: 50    
Potter R, Roes F, Schellong G, Bartenstein P, Bramswig J, Lengerke H, Rath B, Mohring R, Rossi R Subclinical impairment of renal function after radiotherapy for Hodgkin's disease in children. Recent Results Cancer Res 1993, 130: 259-67: 259    
Pötter R, Knocke T, Kovacs G, Schmilowski G, Haverkamp U, Hawliczek R, Seitz W, Rube C, Wuisman P, Maragakis G Brachytherapy in the combined modality treatment of pediatric malignancies. Principles and preliminary experience with treatment of soft tissue sarcoma (recurrence) and Ewing's sarcoma. Klinische Pädiatrie 1995, 207: 164    
Potratz J, Zoubek A, Bielack, S Malignant bone tumors in children and adolescents. Monatsschr Kinderheilkd 2006, 154; 10    
Potratz J, Bielack S Osteosarkome bei Kindern und Jugendlichen - Verbesserte Prognose durch multimodale Therapiekonzepte. pädiatrie hautnah 2; 2006, 66    
Foulon S, Brennan B, Gaspar N, Dirksen U, Jeys L, Cassoni A, Claude L, Seddon B, Marec-Berard P, Whelan J, Paulussen M, Streitbuerger A, Oberlin O, Jürgens H, Grimer R, Le Deley MC Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E. W.I. N.G group. European journal of cancer 2016, 61: 128    
Prados MD, Edwards MS, Chang SM, Russo C, Davis R, Rabbitt J, Page M, Lamborn K, Wara WM Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study. International journal of radiation oncology, biology, physics 1999, 43: 279    
Prante O, Einsiedel J, Haubner R, Gmeiner P, Wester HJ, Kuwert T, Maschauer S 3,4,6-Tri-O-acetyl-2-deoxy-2-[(18)F]fluoroglucopyranosyl Phenylthiosulfonate: A Thiol-Reactive Agent for the Chemoselective (18)F-Glycosylation of Peptides. Bioconjugate chemistry 2007, 18: 254    
Prante O, Einsiedel J, Haubner R, Gmeiner P, Wester HJ, Kuwert T, Maschauer S 3,4,6-Tri-O-acetyl-2-deoxy-2-[(18)F]fluoroglucopyranosyl Phenylthiosulfonate: A Thiol-Reactive Agent for the Chemoselective (18)F-Glycosylation of Peptides. Bioconjugate chemistry 2007, 18: 254    
Prasad P, Vasquez H, Das CM, Gopalakrishnan V, Wolff JE Histone acetylation resulting in resistance to methotrexate in choroid plexus cells. J Neurooncol 2009, 91: 279    
Prabu R, Thulkar S, Chand Sharma M, Mohanti BK, Dhawan D, Bakhshi S PNET spine: morbid and mortal, but ignored till late. Journal of pediatric hematology/oncology 2012, 34:e164    
Preuner S, Peters C, Pötschger U, Daxberger H, Fritsch G, Geyeregger R, Schrauder A, von Stackelberg A, Schrappe M, Bader P, Ebell W, Eckert C, Lang P, Sykora KW, Schrum J, Kremens B, Ehlert K, Albert MH, Meisel R, Lawitschka A, Mann G, Panzer-Grümayer R, Güngör T, Holter W, Strahm B, Gruhn B, Schulz A, Woessmann W, Lion T Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia. Haematologica 2016, 101: 741    
Priolo T, Lamba LD, Giribaldi G, De Negri E, Grosso P, De Grandis E, Veneselli E, Buoncompagni A, Viola S, Alpigiani MG, Gandullia P, Calevo MG Childhood thalidomide neuropathy: a clinical and neurophysiologic study. Pediatric neurology 2008, 38: 196    
Prokop A, Pichlmaier H, Berthold F Peripheral neurogenic tumors--surgical therapy of neuroblastoma. Review and personal results. Zentralbl Chir 1993, 118: 315    
Prokop A, Wieder T, Sturm I, Essmann F, Seeger K, Wuchter C, Ludwig W, Henze G, Dorken B, Daniel P Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo. Leukemia 2000, 14: 1606    
Prosch H, Grois N, Prayer D, Waldhauser F, Steiner M, Minkov M, Gadner H Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Pediatric blood & cancer 2004, 43: 594    
Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010, 115: 168    
Proschmann R, Baldow C, Rothe T, Suttorp M, Thiede C, Tauer JT, Müller MC, Hochhaus A, Roeder I, Glauche I Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy. Haematologica 2016,    
Pruss A, Salama A, Ahrens N, Hansen A, Kiesewetter H, Koscielny J, Dörner T Immune hemolysis-serological and clinical aspects. Clinical and experimental medicine 2003, 3: 55    
Puhlmann U, Reinhardt D, Vorwerk H, Ziemann Ch Association between COX-2 MDR1 expression and MDR1 mediated functional Rhodamine 123 efflux in AML blast. Naunyn-Schmiedeberg's Archives of Pharmakology 2002, 365    
Puhlmann U, Ziemann C, Ruedell G, Vorwerk H, Schaefer D, Langebrake C, Schuermann P, Creutzig U, Reinhardt D Impact of the cyclooxygenase system on doxorubicin-induced functional multidrug resistance 1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells. The Journal of pharmacology and experimental therapeutics 2005, 312: 346    
Pui CH, Boyett JM, Rivera GK, Hancock ML, Sandlund JT, Ribeiro RC, Rubnitz JE, Behm FG, Raimondi SC, Gajjar A, Razzouk B, Campana D, Kun LE, Relling MV, Evans WE Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia 2000, 14: 2286    
Pui CH, Sallan S, Relling MV, Masera G, Evans WE International Childhood Acute Lymphoblastic Leukemia Workshop: Sausalito, CA, 30 November-1 December 2000. Leukemia 2001, 5: 707    
Pui C, Gaynon P, Boyett J, Chessells J, Baruchel A, Kamps W, Silverman L, Biondi A, Harms D, Vilmer E, Schrappe M, Camitta B Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002, 359: 1909    
Pui C, Chessells J, Camitta B, Baruchel A, Biondi A, Boyett J, Carroll A, Eden O, Evans W, Gadner H, Harbott J, Harms D, Harrison C, Harrison P, Heerema N, Janka-Schaub G, Kamps W, Masera G, Pullen J, Raimondi S, Richards S, Riehm H, Sallan S, Sather H, Shuster J, Silverman L, Valsecchi M, Vilmer E, Zhou Y, Gaynon P, Schrappe M Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia 2003, 17: 700    
Pui CH Treatment of Acute Leukemias. New Directions for Clinical Research. Totowa, NJ: Humana Press Inc 2003    
Pui C, Schrappe M, Masera G, Nachman J, Gadner H, Eden O, Evans W, Gaynon P Ponte di Legno Working Group. Leukemia 2004, 18: 1043    
Pui CH Recent advances in childhood acute lymphoblastic leukemia. J Formos Med Assoc 2004, 103: 85    
Pui CH, Relling MV, Downing JR Acute lymphoblastic leukemia. The New England journal of medicine 2004 Apr 8; 350: 1535    
Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV Treating childhood acute lymphoblastic leukemia without cranial irradiation. The New England journal of medicine 2009 Jun 25; 360: 2730    
Purz S, Mauz-Körholz C, Körholz D, Hasenclever D, Krausse A, Sorge I, Ruschke K, Stiefel M, Amthauer H, Schober O, Kranert WT, Weber WA, Haberkorn U, Hundsdörfer P, Ehlert K, Becker M, Rössler J, Kulozik AE, Sabri O, Kluge R [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011, 10; 29: 3523    
Pötter R, Kuhnen C, Ritter J, Rath B, Wuismann P, von Eiff M, von Lengerke HJ, Brämswig J, Paulus S Side-effects after combination therapy for Ewing's sarcoma. Recent Results Cancer Res 1993, 130: 251    
Pötter R, Roes F, Schellong G, Bartenstein P, Bramswig J, von Lengerke H, Rath B, Mohring R, Rossi R Subclinical impairment of renal function after radiotherapy for Hodgkin's disease in children. Recent Results Cancer Res 1993, 130: 259    
Pötter R Paediatric Hodgkin's disease. Eur J Cancer 1999, 35: 1466    
135 items found

The literature database is sorted by the first author's last name - please choose from the alphabet. It comprises the references that were reported by the trial co-ordinating centres and those which are referenced in this information service, for example by the patient information texts.